Thyrocare Technologies
THYROCARE · Healthcare > Hospital & Healthcare Services · Chairman: A Velumani · MD: Dharmil Sheth · Listing date: May 10, 2016 · Employees: 1582 · Navi Mumbai · http://www.thyrocare.com

Stock Price vs Company Growth
1d
1.3%
1w
2.7%
1m
16.1%
3m
4.2%
6m
20.9%
1y
47.3%
5y
8.6%
all
2.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 652 1.3%
556
722
Company Overview

Sales
554 Cr
Growth: 2.7%
Profit after Tax
65.6 Cr
Growth: 1.0%
Small Cap
3,451 Cr
P/E: 53.3x
Industry P/E: 47.3x
Fundamentals

Sales (Cr) ₹ 554
Growth 2.7%
EBITDA 23.2%
P/S 6.2x
Dividend 3.6%
P/E 53.3x
Book Value ₹ 111
PEG Ratio 19.4x
ROE 11.7%
P/B 5.9x
Shareholding Pattern

Institutions
Arisaig Asia Consumer Fund Limited
6.11 %
Nippon Life India Trustee Ltd-A/C Nippon India Nifty Small Cap 250 Index Fund
3.57 %
Fundsmith Emerging Equities Trust Plc
1.46 %
Promoters
Dr.A.Velumani
28.02 %
Thyrocare Publications Llp
12.36 %
Thyrocare Properties And Infrastructure Private Imited
9.88 %
A.Sundararaju Huf
4.57 %
Sumathi Infra Project Llp
2.98 %
Others
Bakak Financial Securities
2.84 %
Llp
0.13 %
Increase    Decrease    No change
Company Profile Detailed

Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia.
Investors (83)
Followers (22)